Loading organizations...
Biopharmaceutical company leveraging AI and big data for drug development.
Great Bay Bio has raised $25.0M across 2 funding rounds.
Great Bay Bio has raised $25.0M in total across 2 funding rounds.
Great Bay Bio has raised $25.0M in total across 2 funding rounds.
Great Bay Bio's investors include Tiger Jade Capital, AEF Greater Bay Area Fund, Vectr Ventures, Proxima Ventures.
Great Bay Bio has raised $25.0M across 2 funding rounds. Most recently, it raised $15.0M Pre-Series B in September 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 15, 2022 | $15.0M Pre-Series B | Tiger Jade Capital | AEF Greater Bay Area Fund, Vectr Ventures |
| Dec 1, 2021 | $10.0M Series A | Proxima Ventures |